Further, Ge et al. recently demonstrated that both BACH2 and its counterpart BCL6 interact with CK2 target Ikaros (IKZF1) resulting in increased BACH2 expression and reduced B-ALL proliferation [45]. The gene discussed is BACH2; the disease is precursor B-cell acute lymphoblastic leukemia.